Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-02-10 00:00:00 ET · period of report 2025-02-06 · accession 0001415889-25-003529 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-10 | 2025-02-06 | TVTX | Baynes Roy D. | Dir | M - OptEx | $17.44 | +10.0K | 41.0K | +32% | +$174.4K |
| D | 2025-02-10 | 2025-02-06 | TVTX | Baynes Roy D. | Dir | S - Sale+OE | $22.00 | -10.0K | 31.0K | -24% | -$220.0K |
| D | 2025-02-10 | 2025-02-06 | TVTX | Baynes Roy D. | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-06 | M | A | 10,000 | $17.44 | 41,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-06 | S | D | 10,000 | $22.00 | 31,000 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2025-02-06 | M | D | 10,000 | $0.00 | 0 | D | $17.44 · — to 2027-05-17 | 10,000 Common Stock | (F2) The stock option is fully vested and exercisable. |